Advanced Search

 

Study ID Status Title Patient Level Data
200699 Completed 200699: A Clinical Study to Evaluate Four Doses of Umeclidinium Bromide in Combination with Fluticasone Furoate in COPD Subjects with an Asthmatic Component
2006-Analysis Completed Paroxetine Adult Suicidality Analysis (2006 Dataset)
200713 Not yet recruiting Characteristics of out-patients with epilepsy and patterns of antiepileptic drug utilisation in neurology department at tertiary hospitals: A Cross-Sectional Study in China
200725 Not yet recruiting TENOZET® Drug Use Investigation
200726 Active, Not Recruiting TENOZET® Special Drug Use Investigation
200773 Completed Pazopanib Sarcoma Named Patient Programme Chart Review
200775 Completed Dabrafenib Melanoma Named Patient Programme Chart Review
200776 Completed Valproate dose reduction and its clinical evaluation by introducing lamotrigine in Japanese women with epilepsy – single arm, multicenter, and open-label study –
200784 Completed A Phase 1, Randomized, Double-Blind (sponsor open), Placebo-Controlled, Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 (anti-CCL20 monoclonal antibody) in Healthy Male Volunteers
200791 Completed Clinical Pharmacology Reporting and Analysis Plan for a Combined Analyses to Evaluate the Effect of Ofatumumab on Cardiac Repolarization (QTc Duration)
200793 Completed TOCTINO® for severe chronic hand eczema – post observation of successful treated patients in TOCCATA
200794 Completed A Pilot Study to Measure Force Recovery and Protein Synthetic Rates After Unilateral Eccentric Exercise in Healthy Males Volunteers Unaccustomed to Eccentric Exercise
200799 Completed Study to compare immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose presentation to the licensed Synflorix™ (10Pn-PD-DiT) vaccine when co-administered with DTPw-combination vaccine in healthy infants
200806 Completed Immunogenicity and safety study of GSK Biologicals’ quadrivalent influenza vaccine (GSK2282512A) in children 6 to 35 months of age Study Listed on ClinicalStudyDataRequest.com
200820 Completed A 12-Week Study to Evaluate the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) 100/25 mcg Once Daily Compared with Vilanterol Inhalation Powder (VI) 25 mcg Once Daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
200862 Completed A Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre 24-week Study to Evaluate the Efficacy and Safety of Mepolizumab Adjunctive Therapy in Subjects with Severe Eosinophilic Asthma on Markers of Asthma Control
200869 Recruiting The Burden of Rhinitis Symptoms in Chinese Patients with Allergic Rhinitis
200883 Recruiting Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve) Observations from Spain
200884 Completed A Randomized, Placebo-Controlled, Double-Blind (Sponsor Unblinded) Study to Investigate Protective Effects of GSK1278863 on Eccentric Exercise Induced Muscle Damage in Healthy Male Volunteers
200896 Active, Not Recruiting Reasons and Consequences for Discontinuation and Adherence with Daily Glucagon-like Peptide-1 Therapies in Type 2 Diabetes Mellitus Patients in the United States
200901 Completed A Phase I, Open label, Randomized, Three period, Fixed Sequence Crossover study to Evaluate the Effect of Carbamazepine on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (200901)
200902 Completed A Randomised, Double-Blind (Sponsor Unblind), Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of Single Ascending Doses of a Fully Humanized Anti-IL-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers
200912 Terminated A Double-Blind, Randomized, Placebo-Controlled, Continuation Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 with and without Ritonavir, and to Evaluate Different Formulations of GSK2838232, in Healthy Subjects
200919 Completed An Open-label Phase 1 Study to Evaluate the Effects of Dabrafenib (GSK2118436) on the Single Dose Pharmacokinetics of an OATP1B1/1B3 Substrate and of a CYP3A4 Substrate in Subjects with BRAF V600 Mutation Positive Tumors
200920 Completed Skin Irritation Study of GSK2894512 Cream-An Evaluator-Blinded Study to Evaluate the Skin Irritation of GSK2894512 Cream and Placebo following Single Application by Simple-Patch Test and Photo-Patch Test, and Repeat Application under non-occlusive condition in Healthy Japanese Subjects Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.